AstraZeneca
Britannica - 03 Jul 2025AstraZeneca ...
astrazeneca
AstraZeneca ...
If AstraZeneca goes to the US, it will be a major blow for London and Labour
The Guardian - 02 Jul 2025If AstraZeneca goes to the US, it will be a major blow for London and Labour ...
Investors fret over talk of AstraZeneca US move
Financial Times - 02 Jul 2025Investors fret over talk of AstraZeneca US move ...
London stock market could face its biggest blow yet if AstraZeneca exits
CNBC - 02 Jul 2025London stock market could face its biggest blow yet if AstraZeneca exits ...
Summit Is in Talks for $15 Billion Partnership With AstraZeneca
Bloomberg.com - 03 Jul 2025Summit Is in Talks for $15 Billion Partnership With AstraZeneca ...
Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors: analyst
Fierce Pharma - 07 Jul 2025Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors: analyst ...
Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports
Reuters - 03 Jul 2025Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports ...
Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug
Yahoo Finance - 06 Jul 2025Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug ...
AstraZeneca exit is a frightening prospect for the City and the government
Sky News - 02 Jul 2025AstraZeneca exit is a frightening prospect for the City and the government ...
AstraZeneca's newest CAR-T play shows first glimpse of clinical activity
FirstWord - 07 Jul 2025AstraZeneca's newest CAR-T play shows first glimpse of clinical activity ...
SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca
TradingView - 07 Jul 2025SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca ...
AstraZeneca receives EU approval for Imfinzi in muscle-invasive bladder cancer
Investing.com - 07 Jul 2025AstraZeneca receives EU approval for Imfinzi in muscle-invasive bladder cancer ...
Summit Therapeutics Stock Soars on Report of $15B AstraZeneca Partnership Talks
Investopedia - 03 Jul 2025Summit Therapeutics Stock Soars on Report of $15B AstraZeneca Partnership Talks ...
CEPI and AstraZeneca to advance discovery into novel antibody to help prevent infection during outbreaks
CEPI - 19 Mar 2025CEPI and AstraZeneca to advance discovery into novel antibody to help prevent infection during outbreaks ...
London Share Listings Hit 30-Year Low Amid AstraZeneca Exit Fears
AskTraders.com - 07 Jul 2025London Share Listings Hit 30-Year Low Amid AstraZeneca Exit Fears ...
AstraZeneca (LSE:AZN) Wins EU Approval For Imfinzi In Muscle-Invasive Bladder Cancer
simplywall.st - 07 Jul 2025AstraZeneca (LSE:AZN) Wins EU Approval For Imfinzi In Muscle-Invasive Bladder Cancer ...
AstraZeneca boss ‘wants to shift stock market listing to US’
The Guardian - 01 Jul 2025AstraZeneca boss ‘wants to shift stock market listing to US’ ...
AstraZeneca circling $15B deal for Summit's PD-1/VEGF bispecific: report
FirstWord - 03 Jul 2025AstraZeneca circling $15B deal for Summit's PD-1/VEGF bispecific: report ...
AstraZeneca considers moving listing to US, the Times reports
Reuters - 01 Jul 2025AstraZeneca considers moving listing to US, the Times reports ...